Get started

Trend Line Break

#MaxHealth is getting ready to heal the pain #SuperChartzKey Levels: Support: 830 Closing Basis Resistance: 900, 999, 1099 Key Drivers: Max Healthcare Institute Limited, India's second-largest hospital chain, offers a diverse array of healthcare services, including complex procedures like transplants, robotic surgeries, cardiac, neuro, orthopedic, and oncology surgeries. They have 17 facilities with a current capacity of ~3,530 beds, boasting a ~75% occupancy rate. Their Max Lab has 435+ partner-run CCs, 23 CoCCs, and ~170 PAS. Max@Home conducts 3,000+ daily billed transactions and has 14 specialized services. Max MyHealth, their digital platform, accounted for ~21% of H1FY24 revenues. They have significant strategic partnerships with Deakin University and Imperial College London, with ~1,000 high-index journal research publications in the last 5 years and 500 completed clinical research projects. Max recently acquired 550 bedded Sahara Hospital for ~Rs. 940 crs and aims to double its bed capacity with a planned brownfield expansion of ~2600 beds and potential to add 1,000 beds through land parcels. They plan to add beds in NCR as follows: FY24: 300 beds for Rs. 918 crs, FY25: 819 beds for Rs. 1592 crs, FY26: 1100 beds for Rs. 1377 crs, FY27: 521 beds for Rs. 552 crs, FY28: 1350 beds. The company has a significant market capitalization of ₹84,041 Cr, with its current stock price at ₹865, fluctuating between a high of ₹910 and a low of ₹412. Its price-to-earnings ratio (P/E) stands high at 79.5, indicating investor optimism. The book value per share is ₹80.7, and the dividend yield is 0.12%. It maintains healthy returns with ROCE at 15.0% and ROE at 16.1%. The operating profit margin (OPM) is robust at 27.9%. The company's EPS is ₹10.9, and it demonstrates strong performance compared to the industry with a return over three months at 39.4% and return over three years at 65.2%. The return on assets is 11.4%, showcasing efficient asset utilization. It generated significant sales of ₹5,198 Cr. The enterprise value is ₹82,910 Cr, with an EVEBITDA ratio of 51.0. The debt-to-equity ratio is low at 0.08, reflecting a healthy financial structure. Overall, the company exhibits strong financials, profitability, and market performance.
NSE:MAXHEALTHLong
by SuperChartz
Technical Analysis and Trade Setup: SJS EnterprisesSJS Enterprises CMP: 636 This stock has been in correction mode for some time now. On Friday, it broke out of a small range and trend line, but the breakout will be confirmed only if it closes above 655. Once the trade becomes active, the stop loss will be set at 585. The targets will be 745, 840, 890, and 970+. Refer to the chart provided to see the support and resistance levels, their flips, and the logic behind the trade. Feel free to share if you found the analysis helpful.
NSE:SJSLong
by iamrk7
Bank Nifty Expiry Trade Analysis! As mentioned earlier post that might be today will be trend day or same tight sideways and it happend market didn't moved to new direction. market players want to stop out as many players as possible before a breakout it started with morning flase break out then all went in a range Bulls are facing strong resistance as they failed twice to break 45600 level and got weaker in later sessions If open below 45200 then sellers will be strong Resistance : 45600,45700 Support : 45200,44900
NSE:BANKNIFTY
by Price_actiontaker14
WARDINMOBI WARDINMOBI . break out trendline with retested wait for Entry .. after entry targets are opens for All. Most Of time i try to share breakout stock own my study . look at on chart going lower low lower high change scenario make higher high wait for break previous high then enter . for MORE check in my TradingView ID If You LIKE MY Idea ……Boost………….. its “Disclosure : I am not Sebi-registered.” This channel is for only educational purpose. Any profit/loss, I am not responsible. Before taking any trade on our charts /calls , please consult your financial advisors. Thanks
BSE:WARDINMOBILong
by asAMOLSUTAR
6